These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 29790294)

  • 1. JAK/STAT Blockade Alters Synovial Bioenergetics, Mitochondrial Function, and Proinflammatory Mediators in Rheumatoid Arthritis.
    McGarry T; Orr C; Wade S; Biniecka M; Wade S; Gallagher L; Low C; Veale DJ; Fearon U
    Arthritis Rheumatol; 2018 Dec; 70(12):1959-1970. PubMed ID: 29790294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT3 Mediates the Differential Effects of Oncostatin M and TNFα on RA Synovial Fibroblast and Endothelial Cell Function.
    Hanlon MM; Rakovich T; Cunningham CC; Ansboro S; Veale DJ; Fearon U; McGarry T
    Front Immunol; 2019; 10():2056. PubMed ID: 31555281
    [No Abstract]   [Full Text] [Related]  

  • 3. Tofacitinib regulates synovial inflammation in psoriatic arthritis, inhibiting STAT activation and induction of negative feedback inhibitors.
    Gao W; McGarry T; Orr C; McCormick J; Veale DJ; Fearon U
    Ann Rheum Dis; 2016 Jan; 75(1):311-5. PubMed ID: 26353790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Janus kinase/signal transducer and activator of transcription (JAK/STAT) signalling pathway in rheumatoid synovial fibroblasts using small molecule compounds.
    Migita K; Izumi Y; Torigoshi T; Satomura K; Izumi M; Nishino Y; Jiuchi Y; Nakamura M; Kozuru H; Nonaka F; Eguchi K; Kawakami A; Motokawa S
    Clin Exp Immunol; 2013 Dec; 174(3):356-63. PubMed ID: 23968543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures.
    Fearon U; Mullan R; Markham T; Connolly M; Sullivan S; Poole AR; FitzGerald O; Bresnihan B; Veale DJ
    Arthritis Rheum; 2006 Oct; 54(10):3152-62. PubMed ID: 17009243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulated bioenergetics: a key regulator of joint inflammation.
    Biniecka M; Canavan M; McGarry T; Gao W; McCormick J; Cregan S; Gallagher L; Smith T; Phelan JJ; Ryan J; O'Sullivan J; Ng CT; Veale DJ; Fearon U
    Ann Rheum Dis; 2016 Dec; 75(12):2192-2200. PubMed ID: 27013493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Activated Synovial Fibroblasts in Rheumatoid Arthritis by Peficitinib.
    Diller M; Hasseli R; Hülser ML; Aykara I; Frommer K; Rehart S; Müller-Ladner U; Neumann E
    Front Immunol; 2019; 10():541. PubMed ID: 30984167
    [No Abstract]   [Full Text] [Related]  

  • 8. The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis.
    Boyle DL; Soma K; Hodge J; Kavanaugh A; Mandel D; Mease P; Shurmur R; Singhal AK; Wei N; Rosengren S; Kaplan I; Krishnaswami S; Luo Z; Bradley J; Firestein GS
    Ann Rheum Dis; 2015 Jun; 74(6):1311-6. PubMed ID: 25398374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The JAK inhibitor baricitinib inhibits oncostatin M induction of proinflammatory mediators in ex-vivo synovial derived cells.
    Weston S; Macdonald JL; Williams LM; Roussou E; Kang NV; Kiriakidis S; Taylor PC
    Clin Exp Rheumatol; 2022 Sep; 40(9):1620-1628. PubMed ID: 34665696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CP690,550 inhibits oncostatin M-induced JAK/STAT signaling pathway in rheumatoid synoviocytes.
    Migita K; Komori A; Torigoshi T; Maeda Y; Izumi Y; Jiuchi Y; Miyashita T; Nakamura M; Motokawa S; Ishibashi H
    Arthritis Res Ther; 2011 May; 13(3):R72. PubMed ID: 21548952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of CCL13 expression in synovial fibroblasts highlights a significant role of oncostatin M in rheumatoid arthritis.
    Hintzen C; Quaiser S; Pap T; Heinrich PC; Hermanns HM
    Arthritis Rheum; 2009 Jul; 60(7):1932-43. PubMed ID: 19565514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-Resistant Pathways Are Associated With Disease Activity in Rheumatoid Arthritis and Are Subject to Disease Modification Through Metabolic Reprogramming: A Potential Novel Therapeutic Approach.
    Gallagher L; Cregan S; Biniecka M; Cunningham C; Veale DJ; Kane DJ; Fearon U; Mullan RH
    Arthritis Rheumatol; 2020 Jun; 72(6):896-902. PubMed ID: 31840936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting JAK-STAT Signalling Alters PsA Synovial Fibroblast Pro-Inflammatory and Metabolic Function.
    O'Brien A; Hanlon MM; Marzaioli V; Wade SC; Flynn K; Fearon U; Veale DJ
    Front Immunol; 2021; 12():672461. PubMed ID: 34248953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipase D enzymes facilitate IL-17- and TNFα-induced expression of proinflammatory genes in rheumatoid arthritis synovial fibroblasts (RASF).
    Friday SC; Fox DA
    Immunol Lett; 2016 Jun; 174():9-18. PubMed ID: 27058440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pattern-recognition receptor nucleotide-binding oligomerization domain--containing protein 1 promotes production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts.
    Yokota K; Miyazaki T; Hemmatazad H; Gay RE; Kolling C; Fearon U; Suzuki H; Mimura T; Gay S; Ospelt C
    Arthritis Rheum; 2012 May; 64(5):1329-37. PubMed ID: 22143988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia and hypoxia-inducible factor-1α provoke toll-like receptor signalling-induced inflammation in rheumatoid arthritis.
    Hu F; Mu R; Zhu J; Shi L; Li Y; Liu X; Shao W; Li G; Li M; Su Y; Cohen PL; Qiu X; Li Z
    Ann Rheum Dis; 2014 May; 73(5):928-36. PubMed ID: 23644550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of JAK-STAT signaling in the pathogenic behavior of fibroblast-like synoviocytes in rheumatoid arthritis: Effect of the novel JAK inhibitor peficitinib.
    Emori T; Kasahara M; Sugahara S; Hashimoto M; Ito H; Narumiya S; Higashi Y; Fujii Y
    Eur J Pharmacol; 2020 Sep; 882():173238. PubMed ID: 32561292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia and STAT3 signalling interactions regulate pro-inflammatory pathways in rheumatoid arthritis.
    Gao W; McCormick J; Connolly M; Balogh E; Veale DJ; Fearon U
    Ann Rheum Dis; 2015 Jun; 74(6):1275-83. PubMed ID: 24525913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress impairs energy metabolism in primary cells and synovial tissue of patients with rheumatoid arthritis.
    Balogh E; Veale DJ; McGarry T; Orr C; Szekanecz Z; Ng CT; Fearon U; Biniecka M
    Arthritis Res Ther; 2018 May; 20(1):95. PubMed ID: 29843785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine.
    Ikeuchi H; Kuroiwa T; Hiramatsu N; Kaneko Y; Hiromura K; Ueki K; Nojima Y
    Arthritis Rheum; 2005 Apr; 52(4):1037-46. PubMed ID: 15818686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.